Search results for: 'funding me1a'

This series gives an overview of the recent developments and transformative trends developing globally as an alternative funding mechanism driving the start-up economy. It creates direct opportunities for companies in sectors such as ICT, business and financial services, health, medical devices and life sciences, supply chain and logistics, retail,...

05 Jul 2017  |  North America  |  Megatrends

Smart Cities Funding Models

Bridging the Funding Gap of the Next Trillion-dollar Market

Infographics

×

Smart Cities are cities built on ‘Smart’ and ‘Intelligent’ solutions and technology which will lead to the adoption of at least 5 of the 8 following smart parameters: smart energy, smart building, smart mobility, smart healthcare, smart infrastructure, smart technology, smart governance and smart education, and smart citizen. The Smart Cities marke...

This research service analyzes the funding scenario in radiation oncology industry sector and provides insights to investors for potential investments into promising technologies and offers strategic recommendations for firms for procuring funds. The study offers strategic analysis and insights on potential technologies worthy of investment and com...

This is a market insight article that discusses the trends in the U.S. speciality funds - utilities and what investment opportunity lies ahead for the funds. The article also briefly covers the U.S. utility industry challenges, market drivers and restraints.

In this research service, Frost & Sullivan presents the US Department of Homeland Security (DHS) Coast Guard (USCG) fiscal year (FY) 2025 spending request, outlining the budget categories, key spending priorities, ongoing acquisition programs, and significant contracts. In addition, the study highlights the key growth-driving and restraining fac...

The rising demand for faster and more secure transactions along with full transparency has made blockchain one of the fastest growing technology markets in the world. Banks and technology providers are investing heavily in R&D activity related to verifying and recording finance transactions. Also, major US technology companies such as IBM, Microsof...

Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companes can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competit...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...